|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-4-1
|
|
pubmed:abstractText |
To investigate the effects of dutasteride on serum testosterone level and body mass index (BMI) in men who received medical therapy for benign prostatic hyperplasia (BPH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
970-4
|
|
pubmed:meshHeading |
pubmed-meshheading:19793378-Adrenergic alpha-Antagonists,
pubmed-meshheading:19793378-Aged,
pubmed-meshheading:19793378-Azasteroids,
pubmed-meshheading:19793378-Body Mass Index,
pubmed-meshheading:19793378-Cholestenone 5 alpha-Reductase,
pubmed-meshheading:19793378-Drug Therapy, Combination,
pubmed-meshheading:19793378-Enzyme Inhibitors,
pubmed-meshheading:19793378-Humans,
pubmed-meshheading:19793378-Male,
pubmed-meshheading:19793378-Middle Aged,
pubmed-meshheading:19793378-Prostatic Hyperplasia,
pubmed-meshheading:19793378-Sulfonamides,
pubmed-meshheading:19793378-Testosterone,
pubmed-meshheading:19793378-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia.
|
|
pubmed:affiliation |
Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
